Maravai LifeSciences Holdings, Inc. (MRVI) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Cygnus Revenue | 18.36M | FY2026-Q1 |
| TriLink Revenue | 47.48M | FY2026-Q1 |
| Nucleic Acid Production Segment Revenue | 25.35M | FY2025-Q3 |
| Biologic Safety Testing Segment Revenue | 16.28M | FY2025-Q3 |
| Adjusted Fully Diluted Earnings (Loss) Per Share | -0.08 USD_per_share | FY2025-Q3 |
Back to MRVI overview · MRVI earnings · MRVI holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.